Stock Events

Stock Events

C4 Therapeutics (CCCC) Q3 2025 Earnings

7AugConfirmed

Q4 2024

Q1 2025

Q2 2025

Q3 2025

-0.49

-0.45

-0.4

-0.35

Details

Expected EPS

-0.384

Actual EPS

-0.37

Surprise EPS

0.01

Surprise Percent

+3.65%

Description

C4 Therapeutics (CCCC) has reported earnings of -0.37 per share for Q3 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.